2,α-Dimethyltryptamine
Chemical compound
Pharmaceutical compound
![]() | |
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C12H16N2 |
Molar mass | 188.274 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
2,α-Dimethyltryptamine (2,α-DMT), also known as 2-methyl-α-methyltryptamine (2-Me-αMT or 2-Me-AMT), is a tryptamine and a lesser-known psychedelic drug. It is the 2,α-dimethyl analog of DMT and the 2-methyl derivative of α-methyltryptamine (αMT or AMT). Its synthesis was first reported in 1965.[1] Alexander Shulgin lists the dosage as 300-500 mg, and the duration as 7–10 hours in his book TiHKAL (Tryptamines I Have Known and Loved).[2] 2,α-DMT causes mydriasis and paresthesia. It also produces a calm, drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,α-DMT.
See also
- 2-Methyltryptamine (2-MT or 2-Me-T)
- 2-Methyl-N,N-diethyltryptamine (2-Me-DET)
- 2,N,N-Trimethyltryptamine (2,N,N-TMT or 2-Me-DMT)
- 5-Methoxy-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT or 2-Me-5-MeO-DMT)
References
- ^ Heath-Brown B, Philpott PG (1965). "Studies in the Indole Series. Part I. Indolylalkylamines". Journal of the Chemical Society (Dec): 7165–7178. doi:10.1039/jr9650007165.
- ^ Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. p. 422. ISBN 0-9630096-9-9. OCLC 38503252.
External links
Tryptamines |
|
---|---|
4-Hydroxytryptamines and esters/ethers |
|
5-Hydroxy- and 5-methoxytryptamines |
|
N-Acetyltryptamines |
|
α-Alkyltryptamines |
|
Triptans | |
Cyclized tryptamines |
|
Isotryptamines | |
Related compounds |
|